Deng Z[au] - Search Results

Year	Number of Results
1979	2
1980	1
1981	1
1982	8
1983	4
1985	10
1986	8
1987	10
1988	11
1989	5
1990	3
1991	7
1992	2
1993	15
1994	17
1995	7
1996	11
1997	27
1998	20
1999	13
2000	25
2001	22
2002	39
2003	38
2004	53
2005	80
2006	107
2007	98
2008	123
2009	149
2010	166
2011	232
2012	273
2013	276
2014	367
2015	404
2016	433
2017	458
2018	518
2019	633
2020	770
2021	823
2022	640

1

3β-Hydroxysteroid dehydrogenase expressed by gut microbes degrades testosterone and is linked to depression in males.

Li D, Liu R, Wang M, Peng R, Fu S, Fu A, Le J, Yao Q, Yuan T, Chi H, Mu X, Sun T, Liu H, Yan P, Wang S, Cheng S, Deng Z, Liu Z, Wang G, Li Y, Liu T. Li D, et al. Among authors: deng z. Cell Host Microbe. 2022 Mar 9;30(3):329-339.e5. doi: 10.1016/j.chom.2022.01.001. Epub 2022 Feb 1. Cell Host Microbe. 2022. PMID: 35108497 Free article.

2

Nuclear Aurora kinase A switches m⁶A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.

Li S, Qi Y, Yu J, Hao Y, He B, Zhang M, Dai Z, Jiang T, Li S, Huang F, Chen N, Wang J, Yang M, Liang D, An F, Zhao J, Fan W, Pan Y, Deng Z, Luo Y, Guo T, Peng F, Hou Z, Wang C, Zheng F, Xu L, Xu J, Wen Q, Jin B, Wang Y, Liu Q. Li S, et al. Among authors: deng z. Signal Transduct Target Ther. 2022 Apr 1;7(1):97. doi: 10.1038/s41392-022-00905-3. Signal Transduct Target Ther. 2022. PMID: 35361747 Free PMC article.

3

Retraction notice to "Serine/threonine kinase BUB1 promotes proliferation and radio-resistance in glioblastoma" [Pathol. - Res. Pract., 215(8), 2019, 152508].

Yu H, Zhang S, Ibrahim AN, Deng Z, Wang M. Yu H, et al. Among authors: deng z. Pathol Res Pract. 2022 May;233:153889. doi: 10.1016/j.prp.2022.153889. Epub 2022 Apr 19. Pathol Res Pract. 2022. PMID: 35452968 No abstract available.

4

Retraction Notice to: Silencing of the MEKK2/MEKK3 Pathway Protects against Spinal Cord Injury via the Hedgehog Pathway and the JNK Pathway.

Kong YL, Wang YF, Zhu ZS, Deng ZW, Chen J, Zhang D, Jiang QH, Zhao SC, Zhang YD. Kong YL, et al. Among authors: deng zw. Mol Ther Nucleic Acids. 2022 May 10;28:600. doi: 10.1016/j.omtn.2022.05.017. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35615008 Free PMC article.

5

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial.

Xia Y, Tang W, Qian X, Li X, Cheng F, Wang K, Zhang F, Zhang C, Li D, Song J, Zhang H, Zhao J, Yao A, Wu X, Wu C, Ji G, Liu X, Zhu F, Qin L, Xiao X, Deng Z, Kong X, Li S, Yu Y, Xi W, Deng W, Qi C, Liu H, Pu L, Wang P, Wang X. Xia Y, et al. Among authors: deng z. J Immunother Cancer. 2022 Apr;10(4):e004656. doi: 10.1136/jitc-2022-004656. J Immunother Cancer. 2022. PMID: 35379737 Free PMC article. Clinical Trial.

6

Progress and prospect of stem cell therapy for diabetic erectile dysfunction.

Luo DS, Li YQ, Deng ZQ, Liu GH. Luo DS, et al. Among authors: deng zq. World J Diabetes. 2021 Dec 15;12(12):2000-2010. doi: 10.4239/wjd.v12.i12.2000. World J Diabetes. 2021. PMID: 35047115 Free PMC article. Review.

7

Two putative parallel pathways for naringenin biosynthesis in Epimedium wushanense.

Liu Y, Wu L, Deng Z, Yu Y. Liu Y, et al. Among authors: deng z. RSC Adv. 2021 Apr 13;11(23):13919-13927. doi: 10.1039/d1ra00866h. eCollection 2021 Apr 13. RSC Adv. 2021. PMID: 35423948 Free PMC article.

8

Quantitative molecular bioluminescence tomography.

Bentley A, Xu X, Deng Z, Rowe JE, Kang-Hsin Wang K, Dehghani H. Bentley A, et al. Among authors: deng z. J Biomed Opt. 2022 Jun;27(6):066004. doi: 10.1117/1.JBO.27.6.066004. J Biomed Opt. 2022. PMID: 35726130 Free PMC article.

9

Discovery of non-squalene triterpenes.

Tao H, Lauterbach L, Bian G, Chen R, Hou A, Mori T, Cheng S, Hu B, Lu L, Mu X, Li M, Adachi N, Kawasaki M, Moriya T, Senda T, Wang X, Deng Z, Abe I, Dickschat JS, Liu T. Tao H, et al. Among authors: deng z. Nature. 2022 Jun;606(7913):414-419. doi: 10.1038/s41586-022-04773-3. Epub 2022 Jun 1. Nature. 2022. PMID: 35650436 Free PMC article.

10

Nanoparticle-delivered Therapeutic Agents Targeting the Tumor Microenvironment for Antitumor Therapy.

Li XT, Peng H, He J, Zhang Z, Gan L, Wu P, Zhong L, Zhao Y, Deng Z, Huang Y. Li XT, et al. Among authors: deng z. Discov Med. 2021 Sep-Oct;32(166):93-107. Discov Med. 2021. PMID: 35219350 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results